NASDAQ:KALA

Kala Pharmaceuticals News Headlines

$7.47
-0.14 (-1.84 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$7.29
Now: $7.47
$7.64
50-Day Range
$6.24
MA: $7.36
$8.09
52-Week Range
$6.00
Now: $7.47
$14.68
Volume1.10 million shs
Average Volume2.30 million shs
Market Capitalization$459.79 million
P/E RatioN/A
Dividend YieldN/A
Beta0.43

Headlines

Kala Pharmaceuticals (NASDAQ KALA) News Headlines Today

SourceHeadline
JPMorgan: 2 Stocks for Stellar Long-Term GainsJPMorgan: 2 Stocks for Stellar Long-Term Gains
finance.yahoo.com - April 14 at 2:50 PM
Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Receives Consensus Rating of "Buy" from AnalystsKala Pharmaceuticals, Inc. (NASDAQ:KALA) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - April 14 at 2:48 AM
Kala Pharmaceuticals, Inc.(KALA)Kala Pharmaceuticals, Inc.(KALA)
fool.com - April 8 at 11:53 AM
Analysts Issue Forecasts for Kala Pharmaceuticals, Inc.s Q1 2022 Earnings (NASDAQ:KALA)Analysts Issue Forecasts for Kala Pharmaceuticals, Inc.'s Q1 2022 Earnings (NASDAQ:KALA)
americanbankingnews.com - April 7 at 6:46 AM
Kala Pharmaceuticals Announces Preferred Position for EYSUVIS™ on CignaKala Pharmaceuticals Announces Preferred Position for EYSUVIS™ on Cigna
finance.yahoo.com - March 16 at 8:09 AM
How Much Are Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Insiders Spending On Buying Shares?How Much Are Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Insiders Spending On Buying Shares?
finance.yahoo.com - March 9 at 12:04 PM
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateKala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - February 25 at 7:48 AM
Heres what Wall Street expects from Kala Pharmaceuticalss earningsHere's what Wall Street expects from Kala Pharmaceuticals's earnings
markets.businessinsider.com - February 24 at 10:44 AM
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference CallKala Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call
finance.yahoo.com - February 18 at 9:45 AM
Global Dry Eye Medication Markets, 2019-2023F, 2025F, 2030FGlobal Dry Eye Medication Markets, 2019-2023F, 2025F, 2030F
markets.businessinsider.com - February 17 at 1:30 PM
Global Dry Eye Medication Market Report 2020: Market is Expected to Recover and Reach $5.1 Billion in 2023 - Forecast to 2030Global Dry Eye Medication Market Report 2020: Market is Expected to Recover and Reach $5.1 Billion in 2023 - Forecast to 2030
benzinga.com - February 15 at 8:06 AM
Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Should You Buy?Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Should You Buy?
finance.yahoo.com - February 3 at 2:48 PM
Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Is Expected To Breakeven In The Near FutureKala Pharmaceuticals, Inc. (NASDAQ:KALA) Is Expected To Breakeven In The Near Future
finance.yahoo.com - February 1 at 8:13 AM
Kala Pharmaceuticals Announces Availability of EYSUVISTM for the Treatment of Dry Eye Disease and Provides Update on Development PipelineKala Pharmaceuticals Announces Availability of EYSUVISTM for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline
finance.yahoo.com - January 7 at 11:43 AM
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in JanuaryKala Pharmaceuticals to Present at Upcoming Investor Conferences in January
finance.yahoo.com - January 4 at 1:34 PM
Investors Who Bought Kala Pharmaceuticals (NASDAQ:KALA) Shares A Year Ago Are Now Up 105%Investors Who Bought Kala Pharmaceuticals (NASDAQ:KALA) Shares A Year Ago Are Now Up 105%
finance.yahoo.com - December 27 at 2:14 PM
KALA Jan 2021 15.000 callKALA Jan 2021 15.000 call
ca.finance.yahoo.com - December 24 at 12:29 AM
KALA Dec 2020 7.500 callKALA Dec 2020 7.500 call
sg.finance.yahoo.com - December 22 at 11:57 PM
KALA Jan 2021 22.500 putKALA Jan 2021 22.500 put
sg.finance.yahoo.com - December 21 at 11:55 PM
KALA Jan 2021 15.000 putKALA Jan 2021 15.000 put
sg.finance.yahoo.com - December 21 at 6:54 PM
KALA Jan 2021 10.000 putKALA Jan 2021 10.000 put
sg.finance.yahoo.com - December 21 at 8:54 AM
Is KALA A Good Stock To Buy Now?Is KALA A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 7:49 PM
KALA Dec 2020 15.000 putKALA Dec 2020 15.000 put
uk.finance.yahoo.com - November 28 at 11:04 PM
Kala Pharmaceuticals (NASDAQ:KALA) Has Debt But No Earnings; Should You Worry?Kala Pharmaceuticals (NASDAQ:KALA) Has Debt But No Earnings; Should You Worry?
finance.yahoo.com - November 27 at 8:57 AM
KALA Dec 2020 12.500 putKALA Dec 2020 12.500 put
ca.finance.yahoo.com - November 25 at 6:43 PM
KALA Dec 2020 5.000 callKALA Dec 2020 5.000 call
ca.finance.yahoo.com - November 23 at 11:10 PM
KALA Dec 2020 2.500 callKALA Dec 2020 2.500 call
uk.finance.yahoo.com - November 23 at 12:42 AM
Kala Pharmaceuticals Provides Update on Launch Plans for EYSUVISTM for the Treatment of Dry Eye DiseaseKala Pharmaceuticals Provides Update on Launch Plans for EYSUVISTM for the Treatment of Dry Eye Disease
finance.yahoo.com - November 16 at 11:13 AM
Kala Pharmaceuticals to Present at the Jefferies 2020 Virtual London Healthcare ConferenceKala Pharmaceuticals to Present at the Jefferies 2020 Virtual London Healthcare Conference
finance.yahoo.com - November 11 at 1:22 PM
Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Analysts Are Pretty Bullish On The Stock After Recent ResultsKala Pharmaceuticals, Inc. (NASDAQ:KALA) Analysts Are Pretty Bullish On The Stock After Recent Results
nasdaq.com - November 8 at 9:37 AM
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q3 2020 Results - Earnings Call TranscriptKala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 8:12 AM
Kala Pharmaceuticals (KALA) Reports Q3 Loss, Tops Revenue EstimatesKala Pharmaceuticals (KALA) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 5 at 1:41 PM
Kala Pharmaceuticals, Inc. to Host Earnings CallKala Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 8:41 AM
Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateKala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 5 at 8:41 AM
Kala Pharmaceuticals Got Its FDA Approval: What’s Next for the StockKala Pharmaceuticals Got Its FDA Approval: What’s Next for the Stock
finance.yahoo.com - October 29 at 11:35 PM
Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - October 29 at 1:33 PM
Kala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference CallKala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call
finance.yahoo.com - October 29 at 8:33 AM
Picking My Spots to Invest My Stash of Cash; Here Are 2 of ThemPicking My Spots to Invest My Stash of Cash; Here Are 2 of Them
realmoney.thestreet.com - October 28 at 6:57 PM
Kala PDUFA, And Other News: The Good, Bad And Ugly Of BiopharmaKala PDUFA, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - October 28 at 1:57 PM
Why Kala Pharmaceuticals Stock Sank TodayWhy Kala Pharmaceuticals Stock Sank Today
finance.yahoo.com - October 27 at 6:50 PM
Kala Pharma Tumbles Despite FDA Approval of Dry Eye DrugKala Pharma Tumbles Despite FDA Approval of Dry Eye Drug
finance.yahoo.com - October 27 at 1:49 PM
FDA Oks Kala Pharmas Eysuvis for dry eye diseaseFDA Oks Kala Pharma's Eysuvis for dry eye disease
seekingalpha.com - October 27 at 8:49 AM
Kala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs and Symptoms of Dry Eye DiseaseKala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease
finance.yahoo.com - October 27 at 8:48 AM
KALA PHARMACEUT. DL-,001 (27F.MU)KALA PHARMACEUT. DL-,001 (27F.MU)
ca.finance.yahoo.com - October 16 at 12:45 PM
Kala Pharmaceuticals (KALA) Looks Good: Stock Adds 6% in SessionKala Pharmaceuticals (KALA) Looks Good: Stock Adds 6% in Session
nasdaq.com - October 6 at 1:19 PM
BUZZ-U.S. STOCKS ON THE MOVE-Mogu Inc, Kala Pharma, Delta Air Lines, Trevana IncBUZZ-U.S. STOCKS ON THE MOVE-Mogu Inc, Kala Pharma, Delta Air Lines, Trevana Inc
nasdaq.com - September 14 at 12:34 PM
Stock Alert: Kala Pharmaceuticals Falls 11% On Lower RatingStock Alert: Kala Pharmaceuticals Falls 11% On Lower Rating
nasdaq.com - September 14 at 12:34 PM
Kala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™Kala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™
finance.yahoo.com - September 10 at 8:11 AM
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in SeptemberKala Pharmaceuticals to Present at Upcoming Investor Conferences in September
finance.yahoo.com - September 8 at 9:48 AM
Have Insiders Been Buying Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Shares?Have Insiders Been Buying Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Shares?
finance.yahoo.com - August 27 at 3:03 PM
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.